Callan Family Office LLC Makes New $677,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Callan Family Office LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 2,254 shares of the company’s stock, valued at approximately $677,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Legacy Investment Solutions LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter worth $39,000. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare during the 3rd quarter worth about $41,000. Whipplewood Advisors LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth about $31,000. Activest Wealth Management boosted its stake in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. boosted its stake in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on HCA. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Royal Bank of Canada decreased their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Finally, Barclays decreased their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is owned by insiders.

HCA Healthcare Trading Up 2.6 %

NYSE HCA opened at $330.11 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market cap of $81.27 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a 50 day moving average price of $316.70 and a 200 day moving average price of $347.49. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the firm posted $5.90 earnings per share. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.87%. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is currently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.